News

Newsletter

13 de April de 2013

Newsletter 2013.02 – Recent developments regarding examination of pharma patent applications

Brazilian PTO’s new Resolution No. 80 of March 19, 2013 sets forth rules for granting priority examination for patent applications related to pharmaceutical products and processes, and equipments and materials related to public health

The Brazilian PTO published Resolution No. 80, on March 19, 2013 in the Official Gazette, which establishes the proceedings for requesting priority examination of patent applications related to pharmaceutical products and processes, and equipments and materials related to public health. We are pleased to hereby enclose a complete English language version of the resolution for your review.

According to the new resolution, now in full force, priority for the examination of patent applications related to public health may be requested by:

Back

Last related news

19 de August de 2026

Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System

Brazil’s National Institute of Industrial Property (INPI) released its new Strategic Plan for 2027–2036 on August 14, 2026. The plan launches a Brazilian PTO Publishes 2027–2036 Strategic Plan: What It Means for Users of Brazil’s IP System

Ler notícia

14 de August de 2026

INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology

On August 11, 2026, the Brazilian Patent and Trademark Office (INPI) announced the launch of the Collaborative Patent Application Examination Project, developed INPI and INDECOPI Launch Collaborative Patent Examination Project Focusing on Pharmaceuticals and Biotechnology

Ler notícia

5 de August de 2026

Bill No. 2,210/2022 Advances in the Senate and Expands the Debate on Brazil’s Patent System

We have been closely monitoring the progress of Bill No. 2,210/2022, which proposes significant amendments to the Brazilian Industrial Property Law, Law Bill No. 2,210/2022 Advances in the Senate and Expands the Debate on Brazil’s Patent System

Ler notícia